---
annotations:
- type: Disease Ontology
  value: cancer
- type: Pathway Ontology
  value: calcium/calcium-mediated signaling pathway
authors:
- Keshav
- DeSl
- Rex D A B
- Egonw
- Khanspers
- Fehrhart
- Eweitz
description: CaMKK2 is a 66â€“68-kDa serine kinase, consists of unique N- and C-terminal
  domains and a central Ser/Thr-directed kinase domain that is followed by a regulatory
  domain composed of overlapping autoinhibitory and CaM-binding regions (PMID:9335539).
  CAMKK2 is activated once calmodulin (CALM1) binds with CAAMKK2. The most well-characterized
  substrates of CaMKK2 are CaMKI, CaMKIV and AMPKÎ±. CaMKK2 phosphorylates CaMKIV,
  CaMKI and AMPKÎ± on activation loop Thr residues (Thr-200, Thr-177 and Thr-172,
  respectively), which increases their kinase activities (PMID:9822657). CaMKK2 is
  present in many areas of the brain, including the olfactory bulb, hippocampus, dentate
  gyrus, amygdala, hypothalamus, and cerebellum (PMID:9822657, 12654522). The creation
  of this pathway is described in [https://pubmed.ncbi.nlm.nih.gov/33136287/ Najar
  et al].
last-edited: 2022-02-26
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4874
- /instance/WP4874
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4874.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: CaMKK2 is a 66â€“68-kDa serine kinase, consists of unique N- and C-terminal
    domains and a central Ser/Thr-directed kinase domain that is followed by a regulatory
    domain composed of overlapping autoinhibitory and CaM-binding regions (PMID:9335539).
    CAMKK2 is activated once calmodulin (CALM1) binds with CAAMKK2. The most well-characterized
    substrates of CaMKK2 are CaMKI, CaMKIV and AMPKÎ±. CaMKK2 phosphorylates CaMKIV,
    CaMKI and AMPKÎ± on activation loop Thr residues (Thr-200, Thr-177 and Thr-172,
    respectively), which increases their kinase activities (PMID:9822657). CaMKK2
    is present in many areas of the brain, including the olfactory bulb, hippocampus,
    dentate gyrus, amygdala, hypothalamus, and cerebellum (PMID:9822657, 12654522).
    The creation of this pathway is described in [https://pubmed.ncbi.nlm.nih.gov/33136287/
    Najar et al].
  keywords:
  - ''
  - 'GDH1 '
  - MTOR
  - Laminar shear stress
  - Betulinic acid
  - FOXO3A
  - CTSE
  - CD28
  - MAPK1
  - MT1
  - CHRM3
  - MAP1LC3B
  - SLCO3A1
  - CREB1
  - ATP1B2
  - STIM1
  - RELA
  - CCND2
  - SLC25A21
  - RASGRP1
  - Protein
  - MAMDC2
  - EPOR
  - 'TBC1D4 '
  - CALM1
  - INN
  - CXCL11
  - Ramipril
  - FASN
  - EP300
  - Hypoxia
  - HDCA4
  - ERMAP
  - TSC2
  - IRGC
  - GALNT9
  - CDH1
  - PLAC8
  - SELL
  - Glyceollin
  - Bupivacaine
  - GIT1
  - Isorhamnetin
  - CAMKK2
  - ICAM1
  - Caulerpin
  - TBXT
  - SPIRE1
  - PCK2
  - CCL5
  - IRS-1
  - MAP1LC3A
  - GATM
  - AKT
  - PARP1
  - VCAM1
  - 'NOS3 '
  - ARHGEF7
  - SPINT1
  - CCR9
  - PPAP2A
  - CCNE1
  - DRP1
  - CYB5R3
  - TRPV4
  - MID1
  - Withdrawal of essential amino acids
  - CRTC2
  - FAM20C
  - RHD
  - TSPAN33
  - SFI1
  - NRF2
  - S100A8
  - AQP1
  - Quercetin
  - WDR35
  - OASL
  - RPS6
  - RHAG
  - 'PAK1 '
  - AHSP
  - NOS1
  - KDR
  - KLF1
  - Hydrogen sulphide
  - FIS1
  - SREBF1
  - NEDD4L
  - Pulsed electric field
  - ACACA
  - PFKFB2
  - Apigenin
  - Theasinensins
  - TSPAN8
  - CAMK4
  - HMBS
  - SLC2A4
  - TSC1
  - Metabolites
  - 'SIRT1 '
  - ASNS
  - HK2
  - Estrogen
  - IL15
  - FAM132a
  - MAPK3
  - NFATC2
  - SQSTM1
  - RPTOR
  - HK1
  - MS4A3
  - ATP10D
  - Eugenol
  - CDC25A
  - MX2
  - SMC1
  - ULK1
  - GCK
  - HIF1A
  - CCND1
  - IFI44L
  - KEAP1
  - Ca2+
  - Oxytocin
  - WFS1
  - MAF
  - Poly unsaturated fatty acids
  - RAC1
  - CAMK1
  - NLRP1
  - HFE
  - SLC38A5
  - PRKCA
  - PFKFB3
  - PRKAA2
  - TNF
  - Homocysteine sulfinic acid
  - ABCA1
  - TREM3
  - TMEM176B
  - Adropin
  - RPS6KB1
  - CPOX
  - EIF4EBP1
  - SLC2A1
  - 'MAPK14 '
  - HMOX1
  - CAR1
  license: CC0
  name: CAMKK2 pathway
seo: CreativeWork
title: CAMKK2 pathway
wpid: WP4874
---